Mira Pharmaceuticals MIRA Growth Metrics (2022-2025)

NASDAQ MIRA
$0.76 +0.03 (+4.60%)
At close: Aug 21, 2026 · 4:00 PM EDT
Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 474.83%-52.69%-40.74%-63.23%78.91%279.52%
Assets Growth (3y) (Quarter) 134.70%
Assets (QoQ) (Quarter) 135.76%-45.31%-22.78%-31.49%-52.09%-37.99%779.09%45.33%
Cash & Equivalents Growth (1y) (Quarter) 3,031.20%1,211.35%261,478.58%-29.37%-38.45%-65.81%-36.26%124.04%
Cash & Equivalents Growth (3y) (Quarter) 141.56%162.48%
Cash & Equivalents (QoQ) (Quarter) 87.27%-99.62%1,740.10%23,540.70%-21.57%-23.33%-31.65%-57.42%-39.44%261.62%140.27%
Cash from Operations Growth (1y) (Quarter) -33.94%-6.11%2.40%-30.74%-4.59%-74.40%-55.31%10.88%40.29%33.52%
Cash from Operations Growth (3y) (Quarter) 5.78%-7.15%
Cash from Operations (QoQ) (Quarter) 25.82%-10.24%38.55%-166.53%41.23%-1.40%17.68%-113.22%2.01%9.70%52.76%-42.86%-9.09%
Dividends Paid - Common (QoQ) (Quarter) -142.38%
Enterprise Value Growth (1y) (Quarter) -3,031.20%-1,211.35%-261,478.58%29.37%38.45%65.81%-81.83%-289.35%
Enterprise Value Growth (3y) (Quarter) -242.59%-215.57%
Enterprise Value (QoQ) (Quarter) -87.27%99.62%-1,740.10%-23,540.70%21.57%23.33%31.65%57.42%39.44%-931.64%-46.37%
EPS (Basic) Growth (1y) (Quarter) -768.25%-62.52%
EPS (Basic) (QoQ) (Quarter) -14.58%78.55%
EPS (Diluted) Growth (1y) (Quarter) -768.25%-99.78%
EPS (Diluted) (QoQ) (Quarter) -14.58%73.64%
FCF Payout Ratio (QoQ) (Quarter) 151.48%
Free Cash Flow Growth (1y) (Quarter) -33.94%-6.11%2.40%-30.74%-4.59%-74.40%-55.31%10.88%40.29%33.52%
Free Cash Flow Growth (3y) (Quarter) 5.78%-7.15%
Free Cash Flow (QoQ) (Quarter) 25.82%-10.24%38.55%-166.53%41.23%-1.40%17.68%-113.22%2.01%9.70%52.76%-42.86%-9.09%
Net Cash Flow Growth (1y) (Quarter) 1,015.10%-873.87%-207.15%-3,102.96%-77.40%-3.62%-51.47%36.71%44.46%377.55%
Net Cash Flow Growth (3y) (Quarter) 70.86%181.29%
Net Cash Flow (QoQ) (Quarter) 125.61%-313.76%106.71%24,793.53%-121.66%15.16%34.36%287.37%-199.31%-24.02%72.57%527.68%90.80%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1,010.37%-149.34%
Net Income towards Common Stockholders (QoQ) (Quarter) -17.41%73.64%
Profit After Tax Growth (1y) (Quarter) -98.15%-328.86%-28.09%-33.58%43.03%58.54%-3.84%9.08%44.34%-147.57%
Profit After Tax Growth (3y) (Quarter) 14.35%-63.89%
Profit After Tax (QoQ) (Quarter) 25.47%0.63%5.59%-183.37%-61.31%70.32%1.54%-20.84%-17.41%25.67%13.79%26.02%-422.19%
Share-based Compensation Growth (1y) (Quarter) 914.88%44.66%238.44%-64.42%-66.67%155.73%-20.03%-75.01%733.60%
Share-based Compensation Growth (3y) (Quarter) -5.44%213.59%
Share-based Compensation (QoQ) (Quarter) 0.00%0.00%1,050.20%-11.76%-85.75%133.95%20.91%-17.33%9.36%-26.84%3,547.18%